Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Triple Negative Breast Neoplasms
×
Oxaliplatin
×
Clear all
Filters
3
NCT05007106
2025-08-14
KEYVIBE-005
Merck Sharp & Dohme LLC
Phase 2
Completed
613 enrolled
NCT01528826
2012-02-08
NVBOX
Fudan University
Phase 2
Unknown
35 enrolled